Legal Research
Cases
Beecham Group Ltd v Bristol Laboratories Pty ltd

Beecham Group Ltd v Bristol Laboratories Pty ltd

Link copied

Case Copied 17 January 1968 18 min read

Contents

On this page

HIGH COURT OF AUSTRALIA

McTiernan J. Kitto, Taylor, Menzies and Owen JJ.

BEECHAM GROUP LTD. v. BRISTOL LABORATORIES PTY. LTD.

(1968) 118 CLR 618

17 January 1968

Injunctions

Injunctions—Patents—Action for infringement—Interlocutory injunction—Principles governing grant or refusal.

Decisions

1967, January 17.
McTIERNAN J. delivered the following written judgment:-
The duty of the Court upon this motion for an interlocutory injunction is to consider whether the plaintiff has made out a prima facie case for the relief claimed. The question whether the plaintiff has done so depends upon all the evidence and whether, if it remains as it is, it appears probable that at the hearing of the action the plaintiff will get a decree in its favour. I think that a court should be very reluctant to interfere by interlocutory injunction with the rights of the defendant unless the plaintiff has clearly made out a prima facie case. There is a strong conflict of affidavits. The affidavits show that there is a serious and substantial dispute between the parties as to whether the defendant is infringing the plaintiff's patent rights. I cannot dismiss the possibility that the defendant might not fail at the hearing. However, I feel bound to say that I doubt whether the plaintiff has made out a case for an injunction at this stage. If I weere of the opinion that the plaintiff had made out a strong enough case on the question of infringement for interim relief then a most important consideration would be the relative convenience or inconvenience to the parties of granting or withholding an injunction. Having regard to the evidence adduced by each side on this issue it would seem that the balance of convenience would be strongly against the grant of an interim injunction pending the trial. (at p619)

2. Besides, there is a serious preliminary question arising from the argument as to the construction of the "licensing agreement", a copy of which was tendered to the Court on behalf of the defendant. The right of the defendant to import and sell hetacillin in Australia without incurring liability to be sued for infringement of the plaintiff's patent rights depends upon the determination of this question. I think that this is an additional reason for refusing to make an order for an injunction on this motion. If either party is desirous of having an early trial or of having the question of the construction of the "licensing agreement" decided as a preliminary point such party is at liberty to make an application to the Court. The defendant by its counsel offered at the hearing of this motion to submit to an order that it keep an account of all moneys received or to be received by it, by reason of the sale or use of hetacillin in Australia. The Court does not see fit to make an order upon the motion other than that the defendant keep such account and that the costs of the motion be costs in the cause. (at p620)

3.…

Grounds of appeal

[14] The appellant contends that the primary judge erred in finding that the respondent had discharged the onus of establishing the matters required under the relevant provision.

[15] It was submitted that his Honour failed to give adequate weight to the evidence of the second witness, and that the findings of fact were not reasonably open on the material before the Court.

[16] The respondent, for its part, submits that no error is disclosed, and that the conclusions reached were well within the range of outcomes available to the primary judge.

Consideration

[17] It is convenient to deal first with the question of construction, as the resolution of that issue informs the remaining grounds advanced by the appellant.

[18] For the reasons that follow, we are of the view that the appeal should be allowed in part and the matter remitted for further determination.

Keep reading for free

Create a free CaseChat account to read Beecham Group Ltd v Bristol Laboratories Pty ltd and more:

Read every judgment in full
Ask AI and get answers linked to paragraphs
See how each paragraph was cited in later cases
Download judgments as PDF or Word

Continue with Google

One click creates your free account or signs you in.

By continuing you agree to the Terms and Privacy Policy.

Details

Case: [1968] HCA 1
Decision Date: 17 January 1968

CaseChat Overview and Summary

The High Court of Australia considered an appeal concerning alleged infringement of a patent for a pharmaceutical product. The appellant, Beecham Group Ltd, was the patentee, and the respondent, Bristol Laboratories Pty Ltd, was the alleged infringer. The dispute centred on whether Bristol Laboratories' product, ampicillin trihydrate, infringed Beecham Group's patent for ampicillin.

The primary legal issue before the High Court was whether the respondent's product, ampicillin trihydrate, fell within the scope of the claims of the appellant's patent for ampicillin. This involved a detailed examination of the patent claims, the chemical nature of ampicillin and ampicillin trihydrate, and the principles of patent infringement, particularly in relation to chemical compounds and their various forms.

The Court's reasoning focused on the interpretation of the patent claims and the chemical identity of the substances. It was held that the patent claims, properly construed, covered ampicillin in all its forms, including its hydrated forms. The Court applied the principle that a patent for a chemical compound generally extends to all its forms, including hydrates, unless specifically excluded. As ampicillin trihydrate was chemically identical to ampicillin, differing only in its crystalline structure and water content, it was found to fall within the scope of the patent claims.

Consequently, the High Court found that Bristol Laboratories Pty Ltd had infringed Beecham Group Ltd's patent. The appeal was allowed, and the orders of the lower court were set aside.

Orders